The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetics, activity, and safety of ODM-201 in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: An open-label phase I trial with long-term extension.
 
Christophe Massard
Honoraria - Orion
Consulting or Advisory Role - Orion
Travel, Accommodations, Expenses - Orion
 
Heidi Penttinen
No Relationships to Disclose
 
Petri Bono
Honoraria - Orion
Consulting or Advisory Role - Orion
Travel, Accommodations, Expenses - Orion
 
Egils Vjaters
No Relationships to Disclose
 
Vilnis Lietuvietis
No Relationships to Disclose
 
Teuvo L. J. Tammela
Consulting or Advisory Role - Orion
Travel, Accommodations, Expenses - Orion
 
Annamari Vuorela
Employment - Orion
 
Pirjo Nykänen
Employment - Orion
 
Pasi Pohjanjousi
Employment - Orion
 
Karim Fizazi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Curevac; Dendreon; Ipsen; Janssen Oncology; Novartis; Orion; Sanofi; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Janssen Oncology; Sanofi
Travel, Accommodations, Expenses - Amgen